clinical_trial

Lecanemab (BAN2401) in Early Alzheimer's Disease (Clarity AD)

created 4/30/2026, 2:41:24 PM

History Diff Edit
completed phase_3 NCT03887455
Intervention
Lecanemab (anti-amyloid monoclonal)
Sponsor
Eisai / Biogen
Registered
Apr 30, 2026

Voting as anonymous. Sign in to attribute your signals.

tokens

Replication

No replications yet

Discussion

Posting anonymously. Sign in for attribution.

No comments yet — be the first.